Stockreport

ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting [Yahoo! Finance]

Oric Pharmaceuticals, Inc.  (ORIC) 
PDF company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts have been accepted for presentation, [Read more]